Publication | Open Access

Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life

Advanced Breast CancerBreast OncologyOncologyCmf Vs EpirubicinPharmacologySingle Agent ChemotherapyBreast CancerMetronomic ChemotherapyCancer TreatmentMedicine